BRNS   $1.23  2.50% Market Closed

Barinthus Biotherapeutics PLC
Total Cash 117.77M
totalCashPerShare 2.988
EBITDA -65.60M
Total Debt 12.57M
quickRatio 7.918
currentRatio 8.46
Total Revenue 0.00
debtToEquity 8.017
Revenue/Share 0.0
ROA -0.19695999
ROE -0.34127998
grossProfits
freeCashflow -33.24M
operatingCashflow -54.62M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -57.74M
forwardPE -0.740679
floatShares 27.36M
sharesOutstanding 39.41M
sharesShort 4.56K
sharesShortPriorMonth 5.82K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.04%
heldPercentInstitutions 0.48%
Short Ratio help_outline 0.23%
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue 3.997
Price To Book help_outline 0.30
earningsQuarterlyGrowth
netIncomeToCommon -63.78M
trailingEps -1.64%
forwardEps -1.62%
enterpriseToEbitda 0.88
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.44 3Q 2024
institutionsCount 21
lastUpdated Oct. 17, 2024, 12:37 p.m.